Kingman Regional Medical Center — Kingman, Arizona

Public research footprint of Kingman Regional Medical Center, compiled from the ClinicalTrials.gov public registry.

125

Registered studies

105

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Ovarian Carcinoma · Locally Advanced Malignant Solid Neoplasm · Botryoid-Type Embryonal Rhabdomyosarcoma · Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma

Recently updated registry entries

NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)
NCT02224781 — Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and… (Active Not Recruiting)
NCT02003222 — Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Kingman Regional Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.